John R. Couchman

John R. Couchman

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


John R. Couchman has a total of 61 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Syndecan‐Mediated Journey

    by John R. Couchman

    A brief, personal, retrospective on my career is presented, focusing on the path that led from studies on fibroblast focal adhesions to the signaling roles of syndecan‐4. This summary is framed against the backdrop of major discoveries in the cell adhesion field that influenced our research direction, ultimately leading to the discovery of signaling events that involve kinases, microfilament dynamics, and ion channels. Syndecan regulation of stretch‐activated transient receptor potential channels appears to be a property that extends back to invertebrates and is probably intrinsic to their origins.


  • Open Access

    Issue Information

    by David S. Katz, Biljana Nikolić, Malcolm Alison, Sarah Howie, Claire E. Lewis, Joseph Boyle, Anne Cooke, Bernard Corfe, John Couchman, Ahmet Doğan, et al.

  • Open Access

    Issue Information

    by D. Katz, Biljana Nikolić, Malcolm Alison, Sarah Howie, Claire E. Lewis, Joseph Boyle, Anne Cooke, Bernard Corfe, John Couchman, Ahmet Doğan, et al.

  • Open Access

    Issue Information

    by D. Katz, Biljana Nikolić, Malcolm Alison, Sarah Howie, Claire E. Lewis, Joseph Boyle, Anne Cooke, Bernard Corfe, John Couchman, Ahmet Doğan, et al.

  • Open Access

    Issue Information

    by D. Katz, Biljana Nikolić, Malcolm Alison, Sarah Howie, Claire E. Lewis, Joseph Boyle, Anne Cooke, Bernard Corfe, John Couchman, Ahmet Doğan, et al.

  • Open Access

    Syndecan-1 (CD138), Carcinomas and EMT

    by John R. Couchman

    Cell surface proteoglycans are known to be important regulators of many aspects of cell behavior. The principal family of transmembrane proteoglycans is the syndecans, of which there are four in mammals. Syndecan-1 is mostly restricted to epithelia, and bears heparan sulfate chains that are capable of interacting with a large array of polypeptides, including extracellular matrix components and potent mediators of proliferation, adhesion and migration. For this reason, it has been studied extensively with respect to carcinomas and tumor progression. Frequently, but not always, syndecan-1 levels decrease as tumor grade, stage and invasiveness and dedifferentiation increase. This parallels experiments that show depletion of syndecan-1 can be accompanied by loss of cadherin-mediated adhesion. However, in some tumors, levels of syndecan-1 increase, but the characterization of its distribution is relevant. There can be loss of membrane staining, but acquisition of cytoplasmic and/or nuclear staining that is abnormal. Moreover, the appearance of syndecan-1 in the tumor stroma, either associated with its cellular component or the collagenous matrix, is nearly always a sign of poor prognosis. Given its relevance to myeloma progression, syndecan-1-directed antibody—toxin conjugates are being tested in clinical and preclinical trials, and may have future relevance to some carcinomas.


  • Open Access

    Syndecan receptors: pericellular regulators in development and inflammatory disease

    by Sandeep Gopal, Samantha Arokiasamy, Csilla Pataki, James R. Whiteford, John R. Couchman

    The syndecans are the major family of transmembrane proteoglycans, usually bearing multiple heparan sulfate chains. They are present on virtually all nucleated cells of vertebrates and are also present in invertebrates, indicative of a long evolutionary history. Genetic models in both vertebrates and invertebrates have shown that syndecans link to the actin cytoskeleton and can fine-tune cell adhesion, migration, junction formation, polarity and differentiation. Although often associated as co-receptors with other classes of receptors (e.g. integrins, growth factor and morphogen receptors), syndecans can nonetheless signal to the cytoplasm in discrete ways. Syndecan expression levels are upregulated in development, tissue repair and an array of human diseases, which has led to the increased appreciation that they may be important in pathogenesis not only as diagnostic or prognostic agents, but also as potential targets. Here, their functions in development and inflammatory diseases are summarized, including their potential roles as conduits for viral pathogen entry into cells.


  • Open Access

    Transforming growth factor-β activation in cell-free extracellular matrix preparations. Commentary

    by John R. Couchman

    Transforming growth factor-β (TGF-β) is an important regulator of many cellular and immunological functions. It is often deposited in extracellular matrices in a latent form. This commentary is to draw attention to the likelihood that preparing cell-free matrices from tissue cultures by high pH buffers, such as ammonium hydroxide, can activate the TGF-β. Therefore, cells subsequently seeded onto such matrices may respond to the presence of active TGF-β in addition to interactions with macromolecular extracellular matrix components. Transforming growth factor-β (TGF-β) is an important regulator of many cellular and immunological functions. It is often deposited in extracellular matrices in a latent form. This commentary is to draw attention to the likelihood that preparing cell-free matrices from tissue cultures by high pH buffers, such as ammonium hydroxide, can activate the TGF-β. Therefore, cells subsequently seeded onto such matrices may respond to the presence of active TGF-β in addition to interactions with macromolecular extracellular matrix components.

  • Cell-extracellular matrix and cell-cell adhesion are linked by syndecan-4

    by Sandeep Gopal, Hinke A.B. Multhaupt, Roger Pocock, John R. Couchman


  • Proteoglycans, ion channels and cell–matrix adhesion

    by Ioli Mitsou, Hinke A.B. Multhaupt, John R. Couchman

    Cell surface proteoglycans comprise a transmembrane or membrane-associated core protein to which one or more glycosaminoglycan chains are covalently attached. They are ubiquitous receptors on nearly all animal cell surfaces. In mammals, the cell surface proteoglycans include the six glypicans, CD44, NG2 (CSPG4), neuropilin-1 and four syndecans. A single syndecan is present in invertebrates such as nematodes and insects. Uniquely, syndecans are receptors for many classes of proteins that can bind to the heparan sulphate chains present on syndecan core proteins. These range from cytokines, chemokines, growth factors and morphogens to enzymes and extracellular matrix (ECM) glycoproteins and collagens. Extracellular interactions with other receptors, such as some integrins, are mediated by the core protein. This places syndecans at the nexus of many cellular responses to extracellular cues in development, maintenance, repair and disease. The cytoplasmic domains of syndecans, while having no intrinsic kinase activity, can nevertheless signal through binding proteins. All syndecans appear to be connected to the actin cytoskeleton and can therefore contribute to cell adhesion, notably to the ECM and migration. Recent data now suggest that syndecans can regulate stretch-activated ion channels. The structure and function of the syndecans and the ion channels are reviewed here, along with an analysis of ion channel functions in cell–matrix adhesion. This area sheds new light on the syndecans, not least since evidence suggests that this is an evolutionarily conserved relationship that is also potentially important in the progression of some common diseases where syndecans are implicated.